| Heather Kae Case, | |
|
10110 Molecular Dr Ste 114, Rockville, MD 20850-7538 | |
| (301) 780-4745 | |
| (301) 605-7550 |
| Full Name | Heather Kae Case |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 10110 Molecular Dr Ste 114, Rockville, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023790730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | R182061 (Maryland) | Primary |
| Entity Name | Maryland Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467173203 PECOS PAC ID: 1052788114 Enrollment ID: O20221102000043 |
News Archive
Though the FDA's Monday approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at risk of contracting the virus "was hailed by many as an important step in the fight against AIDS, concerns that people will incorrectly use the drug - potentially spurring drug resistance - led others to blast the agency for not laying down tougher rules," the Wall Street Journal's "Health Blog" writes.
Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't even significantly alleviate the symptoms. Now, scientists from the Perelman School of Medicine at the University of Pennsylvania and Rutgers University have identified a biological pathway that potentially explains why current asthma therapies don't work well in many cases—and might be targeted to help those patients.
Despite a 1990 consensus recommendation from the National Institutes of Health (NIH) that lumpectomy plus radiation was the treatment of choice for early stage breast cancer, the United States continues to have the highest rate of mastectomy surgery among industrialized countries.
Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announced that it has successfully treated a patient with liver progenitor cells enrolled in its Phase I/II trial.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Kae Case, 10110 Molecular Dr Ste 114, Rockville, MD 20850-7538 Ph: (301) 780-4745 | Heather Kae Case, 10110 Molecular Dr Ste 114, Rockville, MD 20850-7538 Ph: (301) 780-4745 |
News Archive
Though the FDA's Monday approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at risk of contracting the virus "was hailed by many as an important step in the fight against AIDS, concerns that people will incorrectly use the drug - potentially spurring drug resistance - led others to blast the agency for not laying down tougher rules," the Wall Street Journal's "Health Blog" writes.
Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't even significantly alleviate the symptoms. Now, scientists from the Perelman School of Medicine at the University of Pennsylvania and Rutgers University have identified a biological pathway that potentially explains why current asthma therapies don't work well in many cases—and might be targeted to help those patients.
Despite a 1990 consensus recommendation from the National Institutes of Health (NIH) that lumpectomy plus radiation was the treatment of choice for early stage breast cancer, the United States continues to have the highest rate of mastectomy surgery among industrialized countries.
Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announced that it has successfully treated a patient with liver progenitor cells enrolled in its Phase I/II trial.
› Verified 5 days ago
Janice Elaine Hodge, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15825 Shady Grove Rd, Ste 140, Rockville, MD 20850 Phone: 301-869-9776 Fax: 301-216-2592 | |
Lisa Kuester, RN CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9605 Medical Center Dr, Rockville, MD 20850 Phone: 301-330-2921 | |
Ms. Robin Hewitt, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Research Ct Ste 450, Rockville, MD 20850 Phone: 866-389-2727 | |
Veneline Olorife, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 133 Rollins Ave Ste 3, Rockville, MD 20852 Phone: 800-557-8950 | |
Mrs. Jane L Ovedovitz, R.N.,F.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7955 Tuckerman Lane, Rockville, MD 20854 Phone: 646-242-7404 | |
Morgan Gale, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11119 Rockville Pike Ste 204, Rockville, MD 20852 Phone: 301-875-2729 |